Investing

Voyager Therapeutics : VYGR

VYGR

Stock Data

$3.60

$0.10 (2.86%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Voyager Therapeutics Inc is a pioneering biotechnology firm dedicated to developing gene therapies for neurological diseases. With a focus on Alzheimer's disease, their leading project involves VY-TAU01, an innovative anti-tau antibody treatment. Their research extends to potential therapies for amyotrophic lateral sclerosis, Friedreich’s ataxia, Parkinson’s disease, and Huntington’s disease, all in various stages of preclinical trials. Based in Lexington, Massachusetts, Voyager Therapeutics collaborates with notable industry partners like Alexion and Novartis to advance their mission of tackling some of the most challenging neurological disorders.